Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsMolecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureusA mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.Multidrug evolutionary strategies to reverse antibiotic resistance.Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci.Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humansLimits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria.Aminoglycoside resistance 16S rRNA methyltransferases block endogenous methylation, affect translation efficiency and fitness of the host.Friend turned foe: evolution of enterococcal virulence and antibiotic resistanceClinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.Vancomycin and maltodextrin affect structure and activity of Staphylococcus aureus biofilms.Intrinsic and acquired resistance mechanisms in enterococcus.Effects of biofilm growth on plasmid copy number and expression of antibiotic resistance genes in Enterococcus faecalisAntimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Gastrointestinal Tract Colonization Dynamics by Different Enterococcus faecium CladesA Silenced vanA Gene Cluster on a Transferable Plasmid Caused an Outbreak of Vancomycin-Variable Enterococci.VanA-type vancomycin-resistant Staphylococcus aureus.Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?DnaA dynamics could be linked with fitness cost in bacteria.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.Old and New Glycopeptide Antibiotics: Action and Resistance.Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection.Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failureTargeting bactoprenol-coupled cell envelope precursors.Novel blaROB-1-bearing plasmid conferring resistance to β-lactams in Haemophilus parasuis isolates from healthy weaning pigsHaemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.An Unusual Occurrence of Methicillin Resistant Staphylococcal Endocarditis with Vancomycin Creep Phenomenon - A Therapeutic Challenge.Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.Various Sequence Types of Escherichia coli Isolates Coharboring blaNDM-5 and mcr-1 Genes from a Commercial Swine Farm in China.The VanRS Homologous Two-Component System VnlRSAb of the Glycopeptide Producer Amycolatopsis balhimycina Activates Transcription of the vanHAXSc Genes in Streptomyces coelicolor, but not in A. balhimycina.Antibiotic resistance: it's bad, but why isn't it worse?The production of ginsenosides in hairy root cultures of American Ginseng, Panax quinquefolium L. and their antimicrobial activity.Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli.Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria.In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach.Rapid Real-Time Antimicrobial Susceptibility Testing with Electrical Sensing on Plastic Microchips with Printed Electrodes.
P2860
Q24646677-479E044D-FDB4-4501-B899-1F4AE4BA116FQ28078930-2482AEF9-2F5A-4744-9EA1-8CB028CE26D5Q30455758-49143187-EE29-49FE-B975-2DF85F7AF85BQ33871101-C09C09D5-67DB-4A2B-B4FD-9584BBE1F178Q34165648-C6F19C98-418A-4D78-A616-87497FCC582EQ34431997-44BE58E0-9C77-40FC-BEA0-AC0911D1A81DQ35069590-A99AF10F-B87B-41DE-A5E7-208AFCA1B608Q35084648-5450EACC-1A79-461B-B9F1-5DD3ECCB79AFQ35257970-A1E4410D-1A85-4231-AAE3-EFA00BA2D9EEQ35558411-7760DA5F-845A-4E19-962A-CD339E2D5FD7Q35666609-AE02EE60-3DFC-4EB1-A49B-5AF9B63DFE26Q36362547-8644789B-809D-4A09-9094-0C0E0D555EEDQ36757670-9729C9F2-CCC4-4AD8-9B3E-68BCF98E9917Q36757725-61E81BCD-C494-4D5D-BCF9-669F044ECE31Q36931772-D514C5A8-45D2-45DB-9002-42813080236CQ37023221-936A6DFA-F865-417C-A431-069B672E1F3BQ37511373-BE95D861-69CE-4FD7-B401-0CA4203208FBQ37546815-D1AE8733-38F9-4CEB-BF54-3A49BFC3F4D2Q38064807-06485A67-A625-47B2-82FF-44D0E6799141Q38196754-9E465A95-C76F-4C42-A0FF-5264E6405ACBQ38233471-B0E534A4-9D7B-47E0-913A-B1E37D7102BCQ38545589-BC8B8A61-5569-49E3-9D26-D8687F717AB2Q38792892-2EA5C949-5474-46FF-A045-01266A23C26DQ38843037-A70BBC41-63A6-4E0F-89A6-63FA4975F6E2Q38849929-FA0C4B5D-8077-4C6E-8E80-14B2F9FA9FEFQ38873222-3FE10CD3-8BF0-4476-9C3A-CAD80162CF51Q38919751-39FC85A8-BC89-459C-BD40-8EA7D831D4B6Q39519048-DF65659A-F5D0-481D-ABDC-F38F91276C41Q39895516-F14E26AA-0955-4D30-A7C5-0544FA062E0EQ40068591-9CA64AFC-27F0-4F52-A99B-DF4E6430C590Q40199386-99CB0F14-F677-4240-94F6-26289B1A9013Q40403815-5A8C9326-1A4F-4746-B671-9FF7200543F4Q40612247-F5157400-E3F1-4C9E-96E5-3FD36F4D22A8Q41711641-21E39C62-F53A-4F13-B480-C06FA2B97AD8Q41763979-50BFE035-59E5-48EA-ACD5-9FF81A119BA1Q41870270-30A51840-4C06-4D06-84A9-F10AAD438684Q42111453-4A395246-5A0E-4168-9A46-126EE200AD29Q42573010-C6F84B33-3036-46EB-88B6-649B2DD56E61Q42659717-C26F52E5-70A8-41A7-B84D-A60D3EB5CBDAQ47098920-48CAE459-4F44-4F13-BAF2-3B83A1B06A85
P2860
Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Fitness cost of VanA-type vanc ...... esistant Staphylococcus aureus
@en
type
label
Fitness cost of VanA-type vanc ...... esistant Staphylococcus aureus
@en
prefLabel
Fitness cost of VanA-type vanc ...... esistant Staphylococcus aureus
@en
P2093
P2860
P356
P1476
Fitness cost of VanA-type vanc ...... esistant Staphylococcus aureus
@en
P2093
Catherine Grillot-Courvalin
Marie-Laure Foucault
Patrice Courvalin
P2860
P304
P356
10.1128/AAC.01702-08
P407
P577
2009-03-30T00:00:00Z